<DOC>
	<DOC>NCT01148264</DOC>
	<brief_summary>This trial is designed to evaluate olanzapine compared to the metoclopramide in the treatment of break through emesis after prophylaxis with dexamethasone, 5-HT 3 receptor antagonists and aprepitant in patients receiving chemotherapy. Efficacy will be assessed using a modified MASCC questionaire with a visual analog scale.</brief_summary>
	<brief_title>Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>break through emesis after prophylaxis with dexamethasone, 5HT 3 receptor antagonists and aprepitant in patients receiving chemotherapy defined as vomitus or nausea&gt;25mm on VAS signed IC psychiatric disorders drug abuse pregnancy high dose chemotherapy treatment with other antiemetic drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>break-through</keyword>
	<keyword>emesis</keyword>
	<keyword>break through emesis after prophylaxis with dexamethasone, 5-HT 3RA and aprepitant</keyword>
</DOC>